Bringing the Oncology Community Together
Blood Cancer-Related Mutations Commonly Found in Older Individuals
Mutations known to be involved in hematologic malignancies were found in the blood cells of 2%-3% of individuals over age 40 and 5%-6% of those over age 70.
Read More >>
Approval Sought for Ibrutinib in Waldenström's Macroglobulinemia
European Commission Approves Ibrutinib for MCL, CLL
Oral Therapies Shift Treatment Paradigm in CLL
New Strategies Emerge for Managing CLL Patients in Community Settings
CAR Therapy Demonstrates Promise in ALL
Shifting the Paradigm?: Where Is Chemotherapy—and Particularly, High-Dose Therapy—Going in the Era of Biologic Agents?
View More >>
- A Network of Your Peers
View more >>
Dr. Jakubowiak Discusses the Future of Multiple Myeloma Treatment
Dr. Emerson Explains the Connection Between Stem Cell Mutations and Leukemia
Dr. Flinn Discusses the DYNAMO Trial
Most Popular Right Now
Tweets by @OncLive
Lymphoid Malignancy Treatment Considerations
Moderated by Myron S. Czuczman, MD, this panel discussion includes expert perspectives from Steve M. Horwitz, MD, Lauren C. Pinter-Brown, MD, Andrei R. Shustov, MD, and Anas Younes, MD.
Recent Advances in MDS and CML
Moderated by Harry P. Erba, MD, PhD, this panel discussion includes expert perspectives from Mark J. Levis, MD, PhD, Elias J. Jabbour, MD, Rami S. Komrokji, MD, Ruben A. Mesa, MD, and Rafael Bejar, MD, PhD.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.